Schizophrenia Research
Volume 120, Issue 1 , Pages 49-53 , July 2010

Risk syndromes, clinical staging and DSM V: New diagnostic infrastructure for early intervention in psychiatry

  • Patrick D. McGorry

      Affiliations

    • Corresponding Author InformationOrygen Youth Health, Locked Bag 10, Parkville, VIC 3052, Australia. Tel.: +61 3 9342 2850; fax: +61 3 9342 2948.

Received 15 February 2010 ,Accepted 12 March 2010.

References 

  1. Amminger GP, Schafer MR, Papageorgiou K, Klier CM, Cotton SM, Harrigan S, et al. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch. Gen. Psychiatry. 2010;67(2):146–154
  2. Arnett JJ. Emerging adulthood: the winding road from the late teens through the twenties. New York: Oxford University Press; 2004;
  3. Barry S. The secret scripture. London: Faber & Faber; 2008;
  4. Bell RQ. Multiple-risk cohorts and segmenting risk as solutions to the problem of false positives in risk for the major psychoses. Psychiatry. 1992;55(4):370–381
  5. Cannon TD, Cadenhead K, Cornblatt B, Woods SW, Addington J, Walker E, et al. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch. Gen. Psychiatry. 2008;65(1):28–37
  6. Carpenter WT. Anticipating DSM-V: should psychosis risk become a diagnostic class?. Schizophr. Bull. 2009;35(5):841–843
  7. Clarke GN, Hawkins W, Murphy M, Sheeber LB, Lewinsohn PM, Seeley JR. Targeted prevention of unipolar depressive disorder in an at-risk sample of high school adolescents: a randomized trial of a group cognitive intervention. J. Am. Acad. Child Adolesc. Psychiatry. 1995;34(3):312–321
  8. Clarke GN, Hornbrook M, Lynch F, Polen M, Gale J, Beardslee W, et al. A randomized trial of a group cognitive intervention for preventing depression in adolescent offspring of depressed parents. Arch. Gen. Psychiatry. 2001;58(12):1127–1134
  9. Craddock N, Owen MJ. The beginning of the end for the Kraepelinian dichotomy. Br. J. Psychiatry. 2005;186:364–366
  10. Eaton WW, Badawi M, Melton B. Prodromes and precursors: epidemiologic data for primary prevention of disorders with slow onset. Am. J. Psychiatry. 1995;152(7):967–972
  11. Eckersley RM. In: Never Better – Or Getting Worse? Canberra, Australia. 21:2008;
  12. Garber J, Clarke GN, Weersing VR, Beardslee WR, Brent DA, Gladstone TR, et al. Prevention of depression in at-risk adolescents: a randomized controlled trial. JAMA. 2009;301(21):2215–2224
  13. Gordon RS. An operational classification of disease prevention. Public Health Rep. 1983;98(2):107–109
  14. Hafner H. Onset and course of the first schizophrenic episode. Kaohsiung J. Med. Sci. 1998;14(7):413–431
  15. Harrington R, Clark A. Prevention and early intervention for depression in adolescence and early adult life. Eur. Arch. Psychiatry Clin. Neurosci. 1998;248(1):32–45
  16. Hetrick S, Simmons M, Merry S. SSRIs and depression in children and adolescents: the imperative for shared decision-making. Australas. Psychiatry. 2008;16(5):354–358
  17. Insel TR. The arrival of preemptive psychiatry. Early Interv. Psychiatry. 2007;1:5–6
  18. Insel TR. Translating scientific opportunity into public health impact: a strategic plan for research on mental illness. Arch. Gen. Psychiatry. 2009;66(2):128–133
  19. Kraemer HC, Kazdin AE, Offord DR, Kessler RC, Jensen PS, Kupfer DJ. Coming to terms with the terms of risk. Arch. Gen. Psychiatry. 1997;54(4):337–343
  20. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry. 2005;62(6):593–602
  21. Kessler RC, Amminger GP, Aguilar-Gaxiola S, Alonso J, Lee S, Ustun TB. Age of onset of mental disorders: a review of recent literature. Curr. Opin. Psychiatry. 2007;20(4):359–364
  22. McGlashan TH. Early detection and intervention in psychosis: an ethical paradigm shift. Br. J. Psychiatry Suppl. 2005;48:s113–s115
  23. McGlashan TH. Is active psychosis neurotoxic?. Schizophr. Bull. 2006;32(4):609–613
  24. McGorry PD. Paradigm failure in functional psychosis: review and implications. Aust. NZ J. Psychiatry. 1991;25(1):43–55
  25. McGorry PD. Issues for DSM-V: clinical staging: a heuristic pathway to valid nosology and safer, more effective treatment in psychiatry. Am. J. Psychiatry. 2007;164(6):859–860
  26. McGorry PD. Is early intervention in the major psychiatric disorders justified? Yes. Bmj. 2008;337:a695
  27. McGorry PD, Singh BS. Schizophrenia: risk and possibility. In:  Raphael B,  Burrows GD editor. Handbook on studies in preventive psychiatry. Amsterdam: Elsevier; 1995;
  28. McGorry PD, Copolov DL, Singh BS. Current concepts in functional psychosis. The case for a loosening of associations. Schizophr. Res. 1990;3(4):221–234
  29. McGorry PD, Yung AR, Phillips LJ, Yuen HP, Francey S, Cosgrave EM, et al. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch. Gen. Psychiatry. 2002;59(10):921–928
  30. McGorry PD, Yung AR, Phillips LJ. The “close-in” or ultra high-risk model: a safe and effective strategy for research and clinical intervention in prepsychotic mental disorder. Schizophr. Bull. 2003;29(4):771–790
  31. McGorry PD, Hickie IB, Yung AR, Pantelis C, Jackson HJ. Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust. NZ J. Psychiatry. 2006;40(8):616–622
  32. McGorry PD, Purcell R, Hickie IB, Yung AR, Pantelis C, Jackson HJ. Clinical staging: a heuristic model for psychiatry and youth mental health. Med. J. Aust. 2007;187(7 Suppl):S40–S42
  33. McGorry PD, Yung AR, Bechdolf A, Amminger P. Back to the future: predicting and reshaping the course of psychotic disorder. Arch. Gen. Psychiatry. 2008;65(1):25–27
  34. McGorry P, Johanessen JO, Lewis S, Birchwood M, Malla A, Nordentoft M, et al. Early intervention in psychosis: keeping faith with evidence-based health care. Psychol. Med. 2009;1–6
  35. McGorry PD, Nelson B, Amminger GP, Bechdolf A, Francey SM, Berger G, et al. Intervention in individuals at ultra high risk for psychosis: a review and future directions. J Clin Psychiatry. 2009;70(9):1206–1212
  36. Meares A. The diagnosis of prepsychotic schizophrenia. Lancet. 1959;1(7063):55–58
  37. Mrazek P, Haggerty RJ. Reducing risks for mental disorders. Washington DC: National Academy Press; 1994;
  38. Paus T, Keshavan M, Giedd JN. Why do many psychiatric disorders emerge during adolescence?. Nat Rev Neurosci. 2008;9(12):947–957
  39. Phillips LJ, McGorry PD, Yuen HP, Ward J, Donovan K, Kelly D, et al. Medium term follow-up of a randomized controlled trial of interventions for young people at ultra high risk of psychosis. Schizophr. Res. 2007;96(1–3):25–33
  40. Regier DA, Narrow WE, Kuhl EA, Kupfer DJ. The conceptual development of DSM-V. Am. J. Psychiatry. 2009;166(6):645–650
  41. Saraceno B. New knowledge and new hope for people with emerging mental disorders. Early Interv. Psychiatry. 2007;1:3–4
  42. Seeley JR, Stice E, Rohde P. Screening for depression prevention: identifying adolescent girls at high risk for future depression. J. Abnorm. Psychol. 2009;118(1):161–170
  43. Sullivan HS. The onset of schizophrenia. Am. J. Psychiatry. 1927;6:105–134
  44. van Os J, Hanssen M, Bijl RV, Vollebergh W. Prevalence of psychotic disorder and community level of psychotic symptoms: an urban–rural comparison. Arch. Gen. Psychiatry. 2001;58(7):663–668
  45. Woods SW, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, et al. Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr. Bull. 2009;35(5):894–908
  46. Yung A. Prognostic factors for progression to psychosis in high risk youth. Evid. Based Ment. Health. 2008;11(3):72
  47. Yung AR, McGorry PD. The initial prodrome in psychosis: descriptive and qualitative aspects. Aust. NZ J. Psychiatry. 1996;30(5):587–599
  48. Yung AR, McGorry PD. Prediction of psychosis: setting the stage. Br. J. Psychiatry Suppl. 2007;51:s1–s8
  49. Yung AR, McGorry PD, McFarlane CA, Jackson HJ, Patton GC, Rakkar A. Monitoring and care of young people at incipient risk of psychosis. Schizophr. Bull. 1996;22(2):283–303
  50. Yung AR, Phillips LJ, Yuen HP, Francey SM, McFarlane CA, Hallgren M, et al. Psychosis prediction: 12-month follow up of a high-risk (“prodromal”) group. Schizophr. Res. 2003;60(1):21–32
  51. Yung AR, Phillips LJ, Yuen HP, McGorry PD. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr. Res. 2004;67(2–3):131–142
  52. Yung AR, Stanford C, Cosgrave E, Killackey E, Phillips L, Nelson B, et al. Testing the Ultra High Risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people. Schizophr. Res. 2006;84(1):57–66
  53. Yung AR, Yuen HP, Berger G, Francey S, Hung TC, Nelson B, et al. Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk?. Schizophr. Bull. 2007;33(3):673–681
  54. Yung AR, Nelson B, Stanford C, Simmons MB, Cosgrave EM, Killackey E, et al. Validation of “prodromal” criteria to detect individuals at ultra high risk of psychosis: 2year follow-up. Schizophr. Res. 2008;105(1–3):10–17

PII: S0920-9964(10)01186-2

doi: 10.1016/j.schres.2010.03.016

Schizophrenia Research
Volume 120, Issue 1 , Pages 49-53 , July 2010

Article Tools